These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7512939)

  • 1. Sequence of a bovine c-kit proto-oncogene cDNA.
    Kubota T; Hikono H; Sasaki E; Sakurai M
    Gene; 1994 Apr; 141(2):305-6. PubMed ID: 7512939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning and expression of the chicken c-kit proto-oncogene.
    Sasaki E; Okamura H; Chikamune T; Kanai Y; Watanabe M; Naito M; Sakurai M
    Gene; 1993 Jun; 128(2):257-61. PubMed ID: 7685729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.
    Furitsu T; Tsujimura T; Tono T; Ikeda H; Kitayama H; Koshimizu U; Sugahara H; Butterfield JH; Ashman LK; Kanayama Y
    J Clin Invest; 1993 Oct; 92(4):1736-44. PubMed ID: 7691885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A recurrent deletion in the KIT (mast/stem cell growth factor receptor) proto-oncogene is a frequent cause of human piebaldism.
    Spritz RA; Holmes SA; Berg SZ; Nordlund JJ; Fukai K
    Hum Mol Genet; 1993 Sep; 2(9):1499-500. PubMed ID: 7694728
    [No Abstract]   [Full Text] [Related]  

  • 5. Ligand-independent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation.
    Tsujimura T; Furitsu T; Morimoto M; Isozaki K; Nomura S; Matsuzawa Y; Kitamura Y; Kanakura Y
    Blood; 1994 May; 83(9):2619-26. PubMed ID: 7513208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substitution of an aspartic acid results in constitutive activation of c-kit receptor tyrosine kinase in a rat tumor mast cell line RBL-2H3.
    Tsujimura T; Furitsu T; Morimoto M; Kanayama Y; Nomura S; Matsuzawa Y; Kitamura Y; Kanakura Y
    Int Arch Allergy Immunol; 1995 Apr; 106(4):377-85. PubMed ID: 7536501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternate splicing creates two forms of the human kit protein.
    Zhu WM; Dong WF; Minden M
    Leuk Lymphoma; 1994 Feb; 12(5-6):441-7. PubMed ID: 7514064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the promoter region of the human c-kit proto-oncogene.
    Yamamoto K; Tojo A; Aoki N; Shibuya M
    Jpn J Cancer Res; 1993 Nov; 84(11):1136-44. PubMed ID: 7506248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the promoter of the proto-oncogene c-kit.
    Chu TY; Besmer P
    Proc Natl Sci Counc Repub China B; 1995 Jan; 19(1):8-18. PubMed ID: 7539532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The c-kit receptor transduces the stem cell factor-triggered growth signal in murine interleukin-3-dependent cell line.
    Ohashi H; Kameda R; Nishikawa M; Kawagishi M; Liu YC
    Cytotechnology; 1994; 16(1):27-35. PubMed ID: 7531463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the c-kit mRNA in human aortic endothelial cells.
    Miyamoto T; Sasaguri Y; Sugama K; Azakami S; Morimatsu M
    Biochem Mol Biol Int; 1994 Oct; 34(3):513-20. PubMed ID: 7530545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activating mutations of the c-kit proto-oncogene in a human mast cell leukemia cell line.
    Kanakura Y; Furitsu T; Tsujimura T; Butterfield JH; Ashman LK; Ikeda H; Kitayama H; Kanayama Y; Matsuzawa Y; Kitamura Y
    Leukemia; 1994 Apr; 8 Suppl 1():S18-22. PubMed ID: 7512180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic disorders of pigmentation.
    Spritz RA; Hearing VJ
    Adv Hum Genet; 1994; 22():1-45. PubMed ID: 7539206
    [No Abstract]   [Full Text] [Related]  

  • 14. A 1.8-Mb YAC contig spanning three members of the receptor tyrosine kinase gene family (Pdgfra, Kit, and Flk1) on mouse chromosome 5.
    Brunkow ME; Nagle DL; Bernstein A; Bucan M
    Genomics; 1995 Jan; 25(2):421-32. PubMed ID: 7540588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of cytokine receptors by purified hemopoietic stem cells.
    Visser JW; Rozemuller H; de Jong MO; Belyavsky A
    Stem Cells; 1993 Jul; 11 Suppl 2():49-55. PubMed ID: 7691328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-KIT expression enhances the leukemogenic potential of 32D cells.
    Hu Q; Trevisan M; Xu Y; Dong W; Berger SA; Lyman SD; Minden MD
    J Clin Invest; 1995 Jun; 95(6):2530-8. PubMed ID: 7539453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steel factor and c-kit protooncogene: genetic lessons in signal transduction.
    Lev S; Blechman JM; Givol D; Yarden Y
    Crit Rev Oncog; 1994; 5(2-3):141-68. PubMed ID: 7531500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A YAC contig spanning a cluster of human type III receptor protein tyrosine kinase genes (PDGFRA-KIT-KDR) in chromosome segment 4q12.
    Spritz RA; Strunk KM; Lee ST; Lu-Kuo JM; Ward DC; Le Paslier D; Altherr MR; Dorman TE; Moir DT
    Genomics; 1994 Jul; 22(2):431-6. PubMed ID: 7528718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two new polymorphisms but no mutations of the KIT gene in patients with myelodysplasia at positions corresponding to human FMS and murine W locus mutational hot spots.
    Bowen DT; Padua RA; Burnett AK; deCastro CM; Kaufman RE
    Leukemia; 1993 Nov; 7(11):1883-5. PubMed ID: 7694008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel mutations and deletions of the KIT (steel factor receptor) gene in human piebaldism.
    Ezoe K; Holmes SA; Ho L; Bennett CP; Bolognia JL; Brueton L; Burn J; Falabella R; Gatto EM; Ishii N
    Am J Hum Genet; 1995 Jan; 56(1):58-66. PubMed ID: 7529964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.